Emcure, Teva Generics Blocked as Appeal Looms
A New Jersey federal judge on Tuesday blocked Emcure Pharmaceuticals and Teva Pharmaceuticals from proceeding with generic versions of Sunovion Pharmaceuticals' bipolar disorder drug Latuda after the parties agreed to enter a final judgment that allows the defendants to appeal a key claims construction ruling.
This premium content is reserved for New Jersey Law Journal subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now